CA2768727C - Particulate tissue graft with components of differing density and methods of making and using the same - Google Patents
Particulate tissue graft with components of differing density and methods of making and using the same Download PDFInfo
- Publication number
- CA2768727C CA2768727C CA2768727A CA2768727A CA2768727C CA 2768727 C CA2768727 C CA 2768727C CA 2768727 A CA2768727 A CA 2768727A CA 2768727 A CA2768727 A CA 2768727A CA 2768727 C CA2768727 C CA 2768727C
- Authority
- CA
- Canada
- Prior art keywords
- particles
- density
- extracellular matrix
- sheet
- bioresorbable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 49
- 239000002245 particle Substances 0.000 claims abstract description 533
- 239000000203 mixture Substances 0.000 claims abstract description 167
- 230000001737 promoting effect Effects 0.000 claims abstract description 5
- 210000001519 tissue Anatomy 0.000 claims description 153
- 210000002744 extracellular matrix Anatomy 0.000 claims description 114
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 113
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 113
- 239000000463 material Substances 0.000 claims description 66
- 230000008439 repair process Effects 0.000 claims description 55
- 238000002513 implantation Methods 0.000 claims description 46
- 230000000975 bioactive effect Effects 0.000 claims description 30
- 239000007943 implant Substances 0.000 claims description 30
- 238000000576 coating method Methods 0.000 claims description 26
- 239000011248 coating agent Substances 0.000 claims description 24
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 17
- 238000010521 absorption reaction Methods 0.000 claims description 17
- 210000002469 basement membrane Anatomy 0.000 claims description 17
- 229920002674 hyaluronan Polymers 0.000 claims description 17
- 229960003160 hyaluronic acid Drugs 0.000 claims description 17
- 229920000642 polymer Polymers 0.000 claims description 17
- 208000037816 tissue injury Diseases 0.000 claims description 17
- 230000008816 organ damage Effects 0.000 claims description 16
- 230000017423 tissue regeneration Effects 0.000 claims description 16
- 210000003932 urinary bladder Anatomy 0.000 claims description 16
- 238000003801 milling Methods 0.000 claims description 15
- 102000008186 Collagen Human genes 0.000 claims description 14
- 108010035532 Collagen Proteins 0.000 claims description 14
- 229920001436 collagen Polymers 0.000 claims description 14
- 239000011159 matrix material Substances 0.000 claims description 14
- 208000027418 Wounds and injury Diseases 0.000 claims description 10
- 239000013618 particulate matter Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 8
- 210000004876 tela submucosa Anatomy 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 230000006378 damage Effects 0.000 claims description 2
- 208000014674 injury Diseases 0.000 claims description 2
- 238000010030 laminating Methods 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 description 14
- 230000004044 response Effects 0.000 description 12
- 239000003102 growth factor Substances 0.000 description 11
- 239000000499 gel Substances 0.000 description 10
- 210000003041 ligament Anatomy 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 210000000981 epithelium Anatomy 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 210000002435 tendon Anatomy 0.000 description 9
- 206010052428 Wound Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 210000002808 connective tissue Anatomy 0.000 description 6
- 230000002093 peripheral effect Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000000316 bone substitute Substances 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 230000002035 prolonged effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 4
- 239000008177 pharmaceutical agent Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 210000000626 ureter Anatomy 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011246 composite particle Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229940057324 biore Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 239000007771 core particle Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000281 joint capsule Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000003903 pelvic floor Anatomy 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/26—Materials or treatment for tissue regeneration for kidney reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Prostheses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2986673A CA2986673C (en) | 2009-07-22 | 2010-07-21 | Particulate tissue graft with components of differing density and methods of making and using the same |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/507,311 | 2009-07-22 | ||
| US12/507,311 US8652500B2 (en) | 2009-07-22 | 2009-07-22 | Particulate tissue graft with components of differing density and methods of making and using the same |
| PCT/US2010/042701 WO2011011484A2 (en) | 2009-07-22 | 2010-07-21 | Particulate tissue graft with components of differing density and methods of making and using the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2986673A Division CA2986673C (en) | 2009-07-22 | 2010-07-21 | Particulate tissue graft with components of differing density and methods of making and using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2768727A1 CA2768727A1 (en) | 2011-01-27 |
| CA2768727C true CA2768727C (en) | 2018-01-16 |
Family
ID=42709107
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2768727A Active CA2768727C (en) | 2009-07-22 | 2010-07-21 | Particulate tissue graft with components of differing density and methods of making and using the same |
| CA2986673A Active CA2986673C (en) | 2009-07-22 | 2010-07-21 | Particulate tissue graft with components of differing density and methods of making and using the same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2986673A Active CA2986673C (en) | 2009-07-22 | 2010-07-21 | Particulate tissue graft with components of differing density and methods of making and using the same |
Country Status (10)
| Country | Link |
|---|---|
| US (7) | US8652500B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2456476B1 (cg-RX-API-DMAC7.html) |
| JP (5) | JP6226524B2 (cg-RX-API-DMAC7.html) |
| KR (4) | KR20120069668A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102573939B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010276271B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2768727C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2456476T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2749377T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011011484A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7393339B2 (en) | 2003-02-21 | 2008-07-01 | C. R. Bard, Inc. | Multi-lumen catheter with separate distal tips |
| US20040243095A1 (en) | 2003-05-27 | 2004-12-02 | Shekhar Nimkar | Methods and apparatus for inserting multi-lumen spit-tip catheters into a blood vessel |
| US8992454B2 (en) | 2004-06-09 | 2015-03-31 | Bard Access Systems, Inc. | Splitable tip catheter with bioresorbable adhesive |
| EP1765981A4 (en) * | 2004-06-11 | 2007-09-12 | Victorian Tissue Engineering C | WOVEN MATERIAL AND MUSCLE MATRIX |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| US20150359934A1 (en) * | 2007-05-10 | 2015-12-17 | CorMartix Cardiovascular, Inc. | Articles for Tissue Regeneration with Biodegradable Polymer |
| US8500939B2 (en) | 2007-10-17 | 2013-08-06 | Bard Access Systems, Inc. | Manufacture of split tip catheters |
| US8066660B2 (en) | 2007-10-26 | 2011-11-29 | C. R. Bard, Inc. | Split-tip catheter including lateral distal openings |
| US8292841B2 (en) | 2007-10-26 | 2012-10-23 | C. R. Bard, Inc. | Solid-body catheter including lateral distal openings |
| WO2009059220A1 (en) | 2007-11-01 | 2009-05-07 | C.R. Bard, Inc. | Catheter assembly including triple lumen tip |
| US9579485B2 (en) | 2007-11-01 | 2017-02-28 | C. R. Bard, Inc. | Catheter assembly including a multi-lumen configuration |
| WO2009111069A1 (en) * | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| US8652500B2 (en) | 2009-07-22 | 2014-02-18 | Acell, Inc. | Particulate tissue graft with components of differing density and methods of making and using the same |
| US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US9549805B2 (en) * | 2011-12-20 | 2017-01-24 | Lifecell Corporation | Flowable tissue products |
| EP3549615B1 (en) * | 2011-12-20 | 2020-12-16 | LifeCell Corporation | Sheet tissue products |
| KR102223440B1 (ko) | 2013-02-08 | 2021-03-05 | 아셀, 인크. | 세포외 기질 재료로부터의 생리활성 겔의 제조 방법 |
| USD748252S1 (en) | 2013-02-08 | 2016-01-26 | C. R. Bard, Inc. | Multi-lumen catheter tip |
| AU2014218734B2 (en) * | 2013-02-22 | 2018-03-15 | Allosource | Cartilage mosaic compositions and methods |
| US9878071B2 (en) | 2013-10-16 | 2018-01-30 | Purdue Research Foundation | Collagen compositions and methods of use |
| JP6618898B2 (ja) * | 2013-11-19 | 2019-12-11 | コーネル ユニヴァーシティー | 組織再生のための組織スキャフォールド材料および作製方法 |
| US20150283308A1 (en) * | 2014-04-03 | 2015-10-08 | Cook Biotech, Incorporated | Endoluminal device and method of implanting same |
| US10258768B2 (en) | 2014-07-14 | 2019-04-16 | C. R. Bard, Inc. | Apparatuses, systems, and methods for inserting catheters having enhanced stiffening and guiding features |
| KR20170040809A (ko) * | 2014-08-25 | 2017-04-13 | 에이치엘아이 셀룰러 테라퓨틱스, 엘엘씨 | 세포외 기질 조성물 |
| EP3185922B1 (en) | 2014-08-27 | 2025-04-02 | Purdue Research Foundation | Collagen-based therapeutic delivery systems |
| US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
| WO2016172365A1 (en) | 2015-04-21 | 2016-10-27 | Purdue Research Foundation Office Of Technology Commercialization | Cell-collagen-silica composites and methods of making and using the same |
| WO2016187413A1 (en) | 2015-05-21 | 2016-11-24 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
| CN109152635A (zh) * | 2016-03-14 | 2019-01-04 | 雷金蒂斯公司 | 治疗炎性肠病的方法和组合物 |
| US10881555B2 (en) * | 2016-03-30 | 2021-01-05 | Basf Se | Fluid-absorbent article |
| US10537417B2 (en) | 2016-07-07 | 2020-01-21 | Collagen Matrix, Inc. | Density gradient biopolymeric matrix implants |
| JP7242553B2 (ja) | 2017-01-31 | 2023-03-20 | ジェニフィス，インコーポレイテッド | 基質の調製のための方法及び組成物 |
| WO2018200750A1 (en) | 2017-04-25 | 2018-11-01 | Purdue Research Foundation | 3-dimensional (3d) tissue-engineered muscle for tissue restoration |
| AU2019263122B2 (en) | 2018-05-03 | 2022-09-29 | Collplant Ltd. | Dermal fillers and applications thereof |
| CN109513044B (zh) * | 2019-01-29 | 2022-02-18 | 北京颢美细胞基因生物技术有限公司 | 用于微整形的再生组织基质微粒植入剂、制备方法及应用 |
| JP7256395B2 (ja) * | 2019-10-24 | 2023-04-12 | サミー株式会社 | 遊技機 |
| CA3168904A1 (en) | 2020-01-27 | 2021-08-05 | Geniphys, Inc. | Biologic filler for restoring and regenerating tissue |
| US11826490B1 (en) | 2020-12-29 | 2023-11-28 | Acell, Inc. | Extracellular matrix sheet devices with improved mechanical properties and method of making |
| JP2023110424A (ja) * | 2022-01-28 | 2023-08-09 | 国立大学法人信州大学 | 細胞外マトリクス由来の成形体及びその成型体 |
Family Cites Families (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT261800B (de) * | 1966-08-22 | 1968-05-10 | Braun Internat Gmbh B | Verfahren zur Herstellung von röhrenförmigen, glatten bzw. mit einem Gewinde versehenen Gewebe-Blutgefäß-Prothesen |
| US4439521A (en) * | 1981-10-21 | 1984-03-27 | Ontario Cancer Institute | Method for producing self-reproducing mammalian pancreatic islet-like structures |
| US4801299A (en) * | 1983-06-10 | 1989-01-31 | University Patents, Inc. | Body implants of extracellular matrix and means and methods of making and using such implants |
| IL74715A0 (en) * | 1984-03-27 | 1985-06-30 | Univ New Jersey Med | Biodegradable matrix and methods for producing same |
| US4829000A (en) * | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
| US4780450A (en) * | 1985-12-20 | 1988-10-25 | The University Of Maryland At Baltimore | Physically stable composition and method of use thereof for osseous repair |
| GB8618374D0 (en) * | 1986-07-28 | 1986-09-03 | Hsc Res Dev Corp | Biological vascular prostheses |
| US4902528A (en) * | 1987-08-12 | 1990-02-20 | Nestec S.A. | Preparation of dried precooked rice product |
| US4776653A (en) | 1987-10-16 | 1988-10-11 | The Merton Company, Ltd. | Amusement device with kaleidoscope viewer |
| US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
| US4956178A (en) * | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
| JPH02249556A (ja) * | 1988-10-25 | 1990-10-05 | Takao Yamamuro | 骨修復材および人工骨固定化剤 |
| US5425769A (en) * | 1990-04-23 | 1995-06-20 | Snyders, Jr.; Robert V. | Composition of material for osseous repair |
| US5336616A (en) * | 1990-09-12 | 1994-08-09 | Lifecell Corporation | Method for processing and preserving collagen-based tissues for transplantation |
| ES2179821T3 (es) | 1991-06-24 | 2003-02-01 | Hcell Technology Inc | Celulas pancreaticas secretoras de hormonas y mantenimiento en cultivo a largo plazo. |
| US5281422A (en) * | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
| US5800537A (en) * | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
| US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
| US5641518A (en) * | 1992-11-13 | 1997-06-24 | Purdue Research Foundation | Method of repairing bone tissue |
| US5352463A (en) | 1992-11-13 | 1994-10-04 | Badylak Steven F | Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor |
| ES2219660T3 (es) * | 1994-03-14 | 2004-12-01 | Cryolife, Inc | Metodos de preparacion de tejidos para implantacion. |
| US5891558A (en) * | 1994-11-22 | 1999-04-06 | Tissue Engineering, Inc. | Biopolymer foams for use in tissue repair and reconstruction |
| US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
| US6485723B1 (en) * | 1995-02-10 | 2002-11-26 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
| US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
| WO1996031232A1 (en) * | 1995-04-07 | 1996-10-10 | Purdue Research Foundation | Tissue graft and method for urinary bladder reconstruction |
| US5711969A (en) * | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
| CA2172917A1 (en) * | 1995-06-07 | 1996-12-08 | Hugh R. Mcmullin | Moldable collagen compositions for hard tissue repair and augmentation |
| JPH09122227A (ja) * | 1995-10-31 | 1997-05-13 | Bio Eng Lab:Kk | 医用材料およびその製造方法 |
| JPH09122225A (ja) * | 1995-10-31 | 1997-05-13 | Bio Eng Lab:Kk | 医用材料の原料膜材およびその製造方法 |
| ATE258810T1 (de) | 1995-11-09 | 2004-02-15 | Univ Massachusetts | Wiederherstellung der gewebeoberfläche mit zusammensetzungen aus hydrogel-zellen |
| US5869041A (en) * | 1996-01-12 | 1999-02-09 | The Miriam Hospital | Delivery of bioactive compounds to an organism |
| US5755791A (en) * | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
| US6171344B1 (en) * | 1996-08-16 | 2001-01-09 | Children's Medical Center Corporation | Bladder submucosa seeded with cells for tissue reconstruction |
| EP1955721B1 (en) * | 1996-08-23 | 2014-10-29 | Cook Biotech, Inc. | Collagen-based graft prosthesis |
| WO1998019719A1 (en) * | 1996-11-05 | 1998-05-14 | Purdue Research Foundation | Myocardial graft constructs |
| WO1998025546A1 (en) | 1996-12-10 | 1998-06-18 | Cook Biotech, Inc. | Tubular grafts from purified submucosa |
| CA2272097C (en) * | 1996-12-10 | 2007-02-20 | Purdue Research Foundation | Artificial vascular valves |
| CA2274033C (en) | 1996-12-10 | 2010-05-11 | Purdue Research Foundation | Biomaterial derived from vertebrate liver tissue |
| WO1998025545A1 (en) | 1996-12-10 | 1998-06-18 | Cook Biotech, Inc. | Stent grafts containing purified submucosa |
| US5866415A (en) * | 1997-03-25 | 1999-02-02 | Villeneuve; Peter E. | Materials for healing cartilage and bone defects |
| WO1998046165A1 (en) | 1997-04-11 | 1998-10-22 | Cryolife, Inc. | Tissue decellularization |
| ES2175753T3 (es) | 1997-06-27 | 2002-11-16 | Augustinus Bader | Injerto biosintetico y metodo para su produccion. |
| WO1999032607A1 (en) * | 1997-12-23 | 1999-07-01 | Purdue Research Foundation | Biomaterial derived from follicle basement membranes |
| WO1999062427A1 (en) * | 1998-06-05 | 1999-12-09 | Organogenesis Inc. | Bioengineered vascular graft support prostheses |
| CA2342589A1 (en) | 1998-09-11 | 2000-03-23 | Purdue Research Foundation | Enhanced submucosal tissue graft constructs |
| ES2402739T3 (es) * | 1998-11-19 | 2013-05-08 | Organogenesis Inc. | Constructos tisulares modificados por bioingeniería y métodos para producirlos y utilizarlos |
| JP2000223701A (ja) * | 1999-01-28 | 2000-08-11 | Mitsubishi Electric Corp | 半導体装置およびその製造方法 |
| US6322593B1 (en) * | 1999-04-09 | 2001-11-27 | Sulzer Carbomedics Inc. | Method for treating cross-linked biological tissues |
| EP1187909B1 (en) * | 1999-04-30 | 2005-02-02 | Massachusetts General Hospital | Fabrication of threedimensional vascularized tissue using microfabricated two-dimensional molds |
| AU782297B2 (en) * | 1999-06-30 | 2005-07-14 | Ethicon Inc. | Porous tissue scaffoldings for the repair or regeneration of tissue |
| US6454804B1 (en) * | 1999-10-08 | 2002-09-24 | Bret A. Ferree | Engineered tissue annulus fibrosis augmentation methods and apparatus |
| US6432712B1 (en) | 1999-11-22 | 2002-08-13 | Bioscience Consultants, Llc | Transplantable recellularized and reendothelialized vascular tissue graft |
| US6579538B1 (en) * | 1999-12-22 | 2003-06-17 | Acell, Inc. | Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof |
| US6576265B1 (en) * | 1999-12-22 | 2003-06-10 | Acell, Inc. | Tissue regenerative composition, method of making, and method of use thereof |
| US20040043006A1 (en) * | 2002-08-27 | 2004-03-04 | Badylak Stephen F. | Tissue regenerative composition |
| DE60009339T2 (de) | 1999-12-22 | 2004-08-19 | Acell, Inc., Cambridge | Zusammensetzung zur gewebsregeneration |
| US20090053279A1 (en) | 1999-12-22 | 2009-02-26 | Badylak Stephen F | Tissue regenerative composition |
| US6376244B1 (en) * | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
| US6479064B1 (en) * | 1999-12-29 | 2002-11-12 | Children's Medical Center Corporation | Culturing different cell populations on a decellularized natural biostructure for organ reconstruction |
| ATE332964T1 (de) | 2000-08-16 | 2006-08-15 | Univ Duke | Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe |
| US6827966B2 (en) * | 2001-05-30 | 2004-12-07 | Novartis Ag | Diffusion-controllable coatings on medical device |
| CA2452040C (en) | 2001-06-29 | 2011-03-22 | Cook Biotech Incorporated | Porous sponge matrix medical devices and methods |
| US6613348B1 (en) * | 2001-07-31 | 2003-09-02 | Manoj K. Jain | Process of controlling absorbency in collagen flakes |
| EP1446015B1 (en) | 2001-10-18 | 2018-03-14 | Lifecell Corporation | Remodeling of tissues and organs |
| EP2292278B1 (en) | 2001-11-16 | 2013-04-24 | Children's Medical Center Corporation | Augmentation of organ function |
| US6849339B2 (en) * | 2001-11-27 | 2005-02-01 | Guardian Industries Corporation | Composite laminate structures especially useful for automotive trim components, and methods and tie layers employed to make the same |
| US7622299B2 (en) * | 2002-02-22 | 2009-11-24 | University Of Washington | Bioengineered tissue substitutes |
| US6651637B1 (en) * | 2002-10-29 | 2003-11-25 | Transpo Electronics, Inc. | Vehicle ignition system using ignition module with reduced heat generation |
| US20040175366A1 (en) * | 2003-03-07 | 2004-09-09 | Acell, Inc. | Scaffold for cell growth and differentiation |
| US8741352B2 (en) * | 2003-08-25 | 2014-06-03 | Cook Biotech Incorporated | Graft materials containing ECM components, and methods for their manufacture |
| US20050175659A1 (en) * | 2004-02-09 | 2005-08-11 | Macomber Laurel R. | Collagen device and method of preparing the same |
| US20050283256A1 (en) * | 2004-02-09 | 2005-12-22 | Codman & Shurtleff, Inc. | Collagen device and method of preparing the same |
| GB2429162B (en) | 2004-03-29 | 2009-03-25 | Cook Biotech Inc | Methods for producing medical graft products with differing regions |
| EP2093256A3 (en) | 2005-07-28 | 2009-10-14 | Carnegie Mellon University | Biocompatible polymers and methods of use |
| WO2007048831A2 (en) | 2005-10-27 | 2007-05-03 | Coloplast A/S | Biodegradable scaffold with ecm material |
| US7838022B2 (en) * | 2006-05-01 | 2010-11-23 | Warsaw Orthopedic, Inc | Malleable implants containing demineralized bone matrix |
| US7771741B2 (en) * | 2006-05-01 | 2010-08-10 | Warsaw Orthopedic, Inc | Demineralized bone matrix devices |
| US20080005250A1 (en) * | 2006-06-30 | 2008-01-03 | Ragip Dogan Oksum | Messaging System and Related Methods |
| US8535719B2 (en) | 2006-07-07 | 2013-09-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Biohybrid elastomeric scaffolds and methods of use thereof |
| US20080026032A1 (en) | 2006-07-27 | 2008-01-31 | Zubery Yuval | Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use |
| WO2008109407A2 (en) | 2007-03-02 | 2008-09-12 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Extracellular matrix-derived gels and related methods |
| US7799793B2 (en) | 2007-04-27 | 2010-09-21 | Medtronic, Inc. | N-alkylated rifampin |
| WO2009076391A2 (en) * | 2007-12-10 | 2009-06-18 | Cook Biotech Incorporated | Medical materials including modified extracellular matrix materials |
| ES2629613T3 (es) * | 2007-12-12 | 2017-08-11 | Mark K. Moser | Seguidor de fuente luminosa |
| CA2728513C (en) * | 2008-06-20 | 2016-03-15 | Cook Biotech Incorporated | Compressible/expandable medical graft products, and methods for applying hemostasis |
| US8652500B2 (en) | 2009-07-22 | 2014-02-18 | Acell, Inc. | Particulate tissue graft with components of differing density and methods of making and using the same |
-
2009
- 2009-07-22 US US12/507,311 patent/US8652500B2/en active Active
-
2010
- 2010-07-21 KR KR1020127004389A patent/KR20120069668A/ko not_active Ceased
- 2010-07-21 EP EP10737434.0A patent/EP2456476B1/en active Active
- 2010-07-21 WO PCT/US2010/042701 patent/WO2011011484A2/en not_active Ceased
- 2010-07-21 CN CN201080042075.6A patent/CN102573939B/zh active Active
- 2010-07-21 KR KR1020187019501A patent/KR101960694B1/ko not_active Expired - Fee Related
- 2010-07-21 ES ES10737434T patent/ES2749377T3/es active Active
- 2010-07-21 JP JP2012521747A patent/JP6226524B2/ja active Active
- 2010-07-21 KR KR1020167036658A patent/KR101794039B1/ko active Active
- 2010-07-21 DK DK10737434.0T patent/DK2456476T3/da active
- 2010-07-21 CA CA2768727A patent/CA2768727C/en active Active
- 2010-07-21 AU AU2010276271A patent/AU2010276271B2/en active Active
- 2010-07-21 KR KR1020177028050A patent/KR101878236B1/ko active Active
- 2010-07-21 EP EP19194713.4A patent/EP3607975A1/en not_active Withdrawn
- 2010-07-21 CA CA2986673A patent/CA2986673C/en active Active
-
2012
- 2012-11-20 US US13/681,610 patent/US8968761B2/en active Active
-
2014
- 2014-01-24 US US14/163,046 patent/US9056078B2/en active Active
-
2015
- 2015-05-14 US US14/712,084 patent/US9561307B2/en active Active
- 2015-07-23 JP JP2015145739A patent/JP6340346B2/ja active Active
-
2016
- 2016-11-17 US US15/354,236 patent/US11000628B2/en active Active
-
2017
- 2017-09-28 JP JP2017188962A patent/JP6640808B2/ja not_active Expired - Fee Related
-
2018
- 2018-10-12 US US16/158,805 patent/US10898610B2/en active Active
- 2018-11-20 US US16/196,272 patent/US11013829B2/en active Active
-
2019
- 2019-07-19 JP JP2019134133A patent/JP2019193877A/ja active Pending
-
2020
- 2020-01-21 JP JP2020007232A patent/JP2020058884A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11013829B2 (en) | Particulate tissue graft with components of differing density and methods of making and using the same | |
| US11938246B2 (en) | Tissue-based compositions and methods of use thereof | |
| AU2013201872B2 (en) | Particulate tissue graft with components of differing density and methods of making and using the same | |
| HK40013162A (en) | Particulate tissue graft with components of differing density and methods of making and using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140117 |